A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema · Sponsor: Genentech, Inc.
About this study
This study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treated with faricimab. The study population will consist of participants ≥18 years of age who self-identify as Black/African American, Hispanic/Latino American, or Native American/Alaska Native/Native Hawaiian or other Pacific Islander; in addition, a cohort of Asian Indian participants will be enrolled in India.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (43)
| Barnet Dulaney Perkins Eye Center | Phoenix, Arizona, United States | — |
| Win Retina | Arcadia, California, United States | — |
| Retinal Diagnostic Center | Campbell, California, United States | — |
| Retina Consultants of Orange County | Fullerton, California, United States | — |
| Kaiser Permanente Southern California | Los Angeles, California, United States | — |
| Retinal Consultants Medical Group | Sacramento, California, United States | — |
| Southwest Retina Consultants | Durango, Colorado, United States | — |
| Emerson Clinical Research Institute LLC | Washington D.C., District of Columbia, United States | — |
| Blue Ocean Clinical Research | Clearwater, Florida, United States | — |
| Retina Macula Specialists of Miami - LeJeune Road Office | Miami, Florida, United States | — |
| Florida Retina Institute | Orlando, Florida, United States | — |
| Fort Lauderdale Eye Institute | Plantation, Florida, United States | — |
+ 31 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05224102